epinephrine
- Product NDC
- 68083-633
- 11-digit product format
- 680830633
- Labeler code
- 68083
- Product ID
- 68083-633_a7f9fba5-54b0-4001-ba9b-86468e159db7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- epinephrine
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Gland Pharma Limited
- Application
- ANDA219239
- Marketing category
- ANDA
- Marketing start
- 2025-02-06
- Substance
- EPINEPHRINE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- epinephrine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| EPINEPHRINE | 1 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YKH834O4BH |
| Rxcui | 310132 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68083-633-01 | epinephrine | 1 in 1 CARTON | INJECTION | 1 | | 5 |
| 68083-633-01 | epinephrine | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION | 10 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68083-633 | EPINEPHRINE INJECTION [GLAND PHARMA LIMITED] | 3 | Current NDC, 2 package rows | 20250213_79ca73ca-d3c0-40af-9dec-e2f4ce669cda.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 68083-633-01 | 68083063301 | 1 VIAL, MULTI-DOSE in 1 CARTON (68083-633-01) / 10 mL in 1 VIAL, MULTI-DOSE | 2025-02-06 | No | No | Current |